https://www.pharmanation.in/news/cdsco-cancels-fatx-solution-registration-misleading-claims/ PharmaNationen 2026-10-27T16:05:14.602Z CDSCO Cancels FatX Solution Registration Over Misleading Claims: Key Lessons for India’s Cosmetic Industry https://www.pharmanation.in/news/cdsco-approves-zytorvi-toripalimab-oesophageal-cancer-india/ PharmaNationen 2026-10-27T15:05:46.974Z CDSCO Approves Zytorvi for Advanced Oesophageal Cancer in India https://www.pharmanation.in/news/cdsco-approves-qfitlia-fitusiran-india-haemophilia/ PharmaNationen 2026-10-26T04:32:57.329Z CDSCO Approves Qfitlia in India: New Haemophilia Treatment Explained https://www.pharmanation.in/news/india-pharma-marketing-rules-ucpmp-review-2026/ PharmaNationen 2026-10-26T04:24:20.285Z Government Sets Up Panel to Review Pharma Marketing Rules in India